International Journal of Cardiovascular ResearchISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Galina A Sakuta Author

vmorozov.g@gmail.com +7 (812) 552-7901 | +7 (812) 552

Subjects of specialization
Ischemia-modified albumin , Biomarker

Affiliation
Institute of Cytology of the Russian Academy of Sciences, Saint-Petersburg, Russia

Biography

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.

Publications

Research Article Subscription

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

Author(s):

Vladimir I Morozov, Michael I Kalinski, Jason Jaggers, Nikolay V Goncharov and Galina A Sakuta

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers... view more»

DOI: 10.4172/2324-8602.1000157

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP